Friday, April 2, 2021

Medication Guide - 4/2/2021

 

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More

Drug Name Active Ingredient Form;Route Appl. No. Company Date
Lamictal Lamotrigine TABLET;ORAL 020241 GLAXOSMITHKLINE LLC 03/31/2021
Lamictal CD Lamotrigine TABLET, CHEWABLE;ORAL 020764 GLAXOSMITHKLINE LLC 03/31/2021
Lamictal ODT Lamotrigine TABLET, ORALLY DISINTEGRATING;ORAL 022251 GLAXOSMITHKLINE LLC 03/31/2021
Lamictal ODT Lamotrigine TABLET, ORALLY DISINTEGRATING;ORAL 022251 GLAXOSMITHKLINE LLC 03/31/2021
Lamictal XR Lamotrigine TABLET, EXTENDED RELEASE;ORAL 022115 GLAXOSMITHKLINE LLC 03/31/2021
Qsymia Phentermine Hydrochloride; Topiramate CAPSULE, EXTENDED RELEASE;ORAL 022580 VIVUS 03/31/2021
Cipro Ciprofloxacin Hydrochloride TABLET;ORAL 019537 BAYER HLTHCARE 03/30/2021
Cipro Ciprofloxacin FOR SUSPENSION;ORAL 020780 BAYER HLTHCARE 03/30/2021
Cipro XR Ciprofloxacin; Ciprofloxacin Hydrochloride TABLET, EXTENDED RELEASE;ORAL 021473 BAYER HLTHCARE 03/30/2021
Keytruda Pembrolizumab POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER 125514 MERCK SHARP DOHME 03/30/2021
Opdivo Nivolumab INJECTABLE;INJECTION 125554 BRISTOL MYERS SQUIBB 03/30/2021

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment